Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study

D. Gologanu (Bucuresti, Romania), V. Micu (Bucuresti, Romania), V. Nedelcu (Bucuresti, Romania), I. Ion (Bucuresti, Romania), M. Balea (Bucuresti, Romania)

Source: Virtual Congress 2021 – COVID - 19 treatments
Session: COVID - 19 treatments
Session type: E-poster
Number: 3676

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Gologanu (Bucuresti, Romania), V. Micu (Bucuresti, Romania), V. Nedelcu (Bucuresti, Romania), I. Ion (Bucuresti, Romania), M. Balea (Bucuresti, Romania). Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study. 3676

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study)
Source: Annual Congress 2008 - Management of COPD
Year: 2008


Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020
Year: 2020



Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021
Year: 2022



Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
Source: Eur Respir J, 59 (2) 2102275; 10.1183/13993003.02275-2021
Year: 2022



Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



First and second waves results of COVID-19 patients treated with non-invasive respiratory therapies outside the ICU: unicentric, observational study
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Outcome of nicotine replacement therapy in patients admitted to intensive care unit: A randomized case-control double blinded prospective pilot study
Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation
Year: 2011

Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Effects of eight week combined home and outpatient pulmonary rehabilitation in patients with COPD: A Korean multicenter observational study
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

A new treatment algorithm for acute exacerbation of IPF: a retrospective cohort study.
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



Non-responders to outpatient pulmonary rehabilitation: a retrospective, controlled cohort study
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Procalcitonin as a predictor of pneumonia in patients hospitalized with acute exacerbation of COPD: a prospective observational study
Source: International Congress 2017 – COPD biomarkers
Year: 2017